Centene Corporation management check

CNC · Health Care · Managed Health Care · CEO London

Filings as of

47
Management score, ranked 447th of 487 · 54th of 60 in Health Care3 good · 1 to watch · 3 flaggedStrongest: dilution · Weakest: stable leadership · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$69Peers$148

    What $100 became since fiscal 2021

    016th
    Detail

    $100 invested at the start of fiscal 2021 grew to $69, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8350th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.65 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Flag

    What does the CEO cost owners?

    Paid in a loss-making year

    $19.5m pay · −$6.7bn net income, FY2025

    0.1%1%3%10%loss
    016th
    Detail

    $19.5m of reported pay in fiscal 2025, a year the company lost $6.7bn.

  • Watch

    Do they own the stock?

    Insiders are selling

    6 mo: ▲ $0 bought · ▼ $12.1m sold

    ——
    Detail

    2 insiders sold $12.1m in the last six months and none bought.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 591m2025 · 493m

    Diluted shares −4.9% a year; flagged above +2%

    0%10%20%

    Stock pay 0.1% of revenue

    100100th
    Detail

    Diluted shares changed -4.9% a year over the last three fiscal years. Stock-based pay was 0.1% of revenue in the latest year.

  • Flag

    Is leadership stable?

    3 CEOs in the pay table

    13 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Neidorff, London, Neidorf

    04th
    Detail

    CEOs in the pay table: Neidorff, London, Neidorf. 13 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 26, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$21.2m$42.3m$10020212022202320242025$69$148

Pay tied most to Adjusted Diluted EPS

Other key measuresTSRAdjusted Net Earnings MarginTotal Shareholder Return (TSR)Adjusted Pre-tax MarginRevenue Growth Compound Annual Growth

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025London$19.5m$4.6m$7.7m$69$148−$6.7bn
2024London$20.6m$5.4m$7.2m$101$129$3.3bn
2023London$18.6m$14.0m$7.6m$124$126$2.7bn
2022London, Neidorf$13.2m$12.6m$6.7m$137$124$1.2bn
2021Neidorff$20.6m$42.3m$9.9m$137$126$1.3bn

Insiders and the CEO's stakeSelling

2 insiders sold $12.1m in the last six months and none bought.

Open-market trades by officers and directors since May 21, 2026.

  • SoldChristopher KosterSecretary & General Counsel$6.9mAug 26, 2026
  • SoldKenneth A BurdickDirector$5.2mJun 10, 2026

Leadership and governance on file

20222023202420252026Leadership 24Votes 6
All 24 filings

Latest shareholder vote results: May 15, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $8.6bn returned to owners in buybacks and dividends, 458% of net income, and $1.1bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
−$6.7bn−$1.7bn$3.3bn20212022202320242025Shares591m582m546m524m493m
Show the figures
Fiscal year20212022202320242025
Revenue$118.0bn$135.5bn$140.1bn$145.5bn$174.6bn
Net income$1.3bn$1.2bn$2.7bn$3.3bn−$6.7bn
Stock-based pay$203.0m$234.0m$216.0m$212.0m$204.0m
Buybacks$297.0m$3.1bn$1.6bn$3.1bn$475.0m
Dividends—————
Diluted shares591m582m546m524m493m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.